Brian joined AbbVie in 2018 as the head of the newly formed RAIDERS team within Research & Development’s Information Research division, focused on accelerating, scaling, and amplifying the work of AbbVie’s R&D community using Artificial Intelligence technologies like machine learning, deep learning, graph computation, and cognitive computing. Brian is a part of the leadership team building and directing the AbbVie R&D Convergence Hub (ARCH) as part of the R&D Convergence initiative and a member of the ACOS Scientific Innovation Council. Brian came to AbbVie after spending five years in technology consulting across many industries, and over a decade of additional experience before that working in trading and financial markets technology. During his consulting time, Brian was the architect of the United States’ Common Securitization Platform and the technology founder of Publicis.Sapient’s AI practice. While his primary focus is AI technologies, he was also a co-founder of the QuPharm quantum computing community and the Pistoia/QED-C Quantum Community of Interest. He is a frequent presenter at conferences on topics as diverse as optical networking, quantum computing, blockchain, cognitive architecture, and other emerging technologies that are all part of digital transformation.
Brian holds a B.S. degree in Computer and Cognitive Science from Alma College and a M.S in Computer Science from the University of Chicago. He is a board member for the Chicago Innovative Executives League and for the Mundelein High School Business Incubator program. He has been involved with the Creative Destruction Lab at the University of Toronto’s Rotman School and as a panelist/reviewer for the National Science Foundation Secure and Trusted Cyberspace grant division. Brian lives in Lake Bluff, Illinois with his wife and four children.